Application of HBx-induced anti-URGs as early warning biomarker of cirrhosis and HCC

Cancer Biomarkers

Volumn 11, Issue 1, 2011, Pages 29-39

  Wang, Wen ^a   Zhao, Lan Juan ^a   Wang, Yan ^a   Tao, Qing Yuan ^a   Feitelson, Mark A ^a,b   Zhao, Ping ^a   Ren, Hao ^a   Qi, Zhong Tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Temple University   (United States)

Author keywords

Anti URGs; biomarker; early diagnosis; hepatitis B virus x antigen; Hepatocellular carcinoma

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; GAMMA GLUTAMYLTRANSFERASE; GLYPICAN 3; HEPATITIS B ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BILE DUCT CARCINOMA; BLOOD DONOR; BLOOD SAMPLING; CHRONIC HEPATITIS; CONTROL GROUP; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HEPATITIS B VIRUS; HIGH RISK PATIENT; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SERUM; VIRUS CARRIER;

ADULT; AGED; AREA UNDER CURVE; CARCINOMA, HEPATOCELLULAR; EARLY DETECTION OF CANCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; ROC CURVE; TRANS-ACTIVATORS; TRANSCRIPTOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84864432828     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2012-0261     Document Type: Article

References (33)

1. Feitelson MA. HBV and cancer. In: Notkins AL, Oldstone MBA, editors. Concepts in viral pathogenesis. New York: Springer-Verlag; 1986. p. 269-275.
2. Beasley RP, Hwang LY. Epidemiology of hepatocellular carcinoma. In: Vyas GN, Dienstag JL, Hoofnagle JH, editors. Viral hepatitis and liver disease. New York: Grune and Stratton; 1994. pp. 209-224.
3. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and HBV. A prospective study of 22,707 men in Taiwan. Lancet 1981; 2:1129-1133.
4. RossnerMT.Hepatitis B virus X-gene product: A promiscuous transcriptional activator. J Med Virol 1992; 36:101-117.
5. Henkler F, Koshy R. Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis. J Viral Hepat 1996; 3:109-121.
6. Bouchard MJ,Wang LH, Schneider RJ. Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science (Wash DC) 2001; 294:2376-2378.
7. Nakatake H, Chisaka O, Yamamoto S, Matsubara K, Koshy R. Effect of X protein on transactivation of HBV promoters and on viral replication. Virology 1993; 195:305-314.
8. Caselmann WH. Transactivation of cellular gene expression by hepatitis B viral proteins: A possible mechanism of hepatocarcinogenesis. J Hepatol 1995; 22(Suppl 1):34-37.
9. Koshy R, Hofschneider PH. Transactivation by hepatitis B virus may contribute to hepatocarcinogenesis. Curr Top in Microbiol Immunol 1989; 144:265-281.
10. Tackels-Horne D, Goodman MD, Williams AJ, Wilson DJ, Eskandari T, et al. Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling.Cancer 2001; 92:395-405.
11. Shirota Y, Kaneko S, Honda M, Kawai HF, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001; 33:832-840.
12. Chen X, Cheung ST, So S, Fan ST, Barry C, et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13:1929-1939.
13. Xu XR, Huang J, Xu ZG, Qian BZ, Zhu ZD, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001;98:15089-15094.
14. Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, et al. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Cancer (Phila) 2003; 97:2474-2479.
15. Lian Z, Pan J, Liu J, Zhang S, Zhu M, et al. The translation initiation factor, SUI1, may be a target of hepatitis B x antigen in hepatocarcinogenesis. Oncogene 1999; 18:1677-1687.
16. Lian Z, Liu J, Pan J, Satiroglu Tufan NL, Zhu M, et al. A cellular gene upregulated by hepatitis B virus encoded X antigen promotes hepatocellular growth and survival. Hepatology 2001; 34:146-157.
17. Tufan NLS, Lian Z, Liu J, Pan J, Arbuthnot P, et al. Hepatitis B x antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.Neoplasia 2002;4:355-368.
18. Lian Z, Liu J, Li L, Li X, Tufan NL, et al. Up-regulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis. Neoplasia 2003; 5:229-244.
19. Lian Z, Liu J, Li L, Li X, Tufan NL, et al. Human S15a is an effector which is up-regulated by HBV X protein. Mol Carcinogen 2004; 40:34-46.
20. Hann, J.MLee, Lee J, Bussard A, Liu C, Jin YR, et al. Preneoplastic Markers of Hepatitis B Virus-Associated Hepatocellular Carcinoma. Cancer Research 2004; 64(15):7329-7335.
21. Luber B, Arnold N, Sturzl M, Höhne M, Schirmacher P, et al. Hepatoma-derived integratiod HBV DNA causes multi-stage transformation in vitro. Oncogene 1996; 12:1597-1608.
22. Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature (Lond) 1991; 351:317-320.
23. KoikeK,MoriyaK, Iino S,Yotsuyanagi H, EndoY, et al.Highlevel expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 1994; 19:810-819.
24. Henkler F, Koshy R. Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis. J Viral Hepat 1996; 3:109-121.
25. Feitelson MA, Duan LX. Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 1997; 150:1141-1157.
26. WangW,Wang JH,Miao XH, Feitelson MA, Qi ZT.Detection of serummarkers of hepatocellular carcinoma by ELISA using synthesized peptides. Chinese Journal of Biologicals, 2009, 22(4): 399-401.
27. Lee JY, Culvenor JG, Angus P, Smallwood R, Nicoll A, et al. Duck hepatitis B virus replication in primary bile duct epithelial cells. J Virol 2001; 75:7651-761.
28. Wang WL, London WT, Feitelson MA. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res 1991; 51:4971-4977.
29. KewMC.Hepatocellular carcinoma inAfricanBlacks: Recent progress in etiology and pathogenesis. World J Hepatology 2010; 2:65-273.
30. Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol 2000; 95: 1535-1538.
31. Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and desgamma- carboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci 2007; 52: 776-782.
32. Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, et al. Utility of Lens culinaris agglutinin-reactive fraction of alphafetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol 2009; 7: 104-113.
33. Piotr Stefaniuk, Janusz Cianciara, Alicja Wiercinska-Drapalo. Present and future possibilities for early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2010; 16(4): 418-424.